X4 Pharmaceuticals stock sheds 14% on proposed securities offering
X4 Pharmaceuticals (NASDAQ:XFOR) shares down 14.17% after-hours after the firm has commenced an underwritten public offering of shares of its common stock and accompanying warrants to purchase shares of its common stock .
It expects to grant the underwriters a 30-day option to purchase additional shares of its common stock and/or warrants to purchase shares of its common stock at the public offering price.
All of the securities in the offering will be sold by X4.
There can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.
